Search research articles
Contact Us
Filters
Showing results (321-330 of 349) with videos related to
Page
of 35
Sort By:
Frontiers in Immunology
|
July 25, 2022
Dynamics of Melanoma-Associated Epitope-Specific CD8+ T Cells in the Blood Correlate With Clinical Outcome Under PD-1 Blockade
Andrea Gaißler, Trine Sundebo Meldgaard, Christina Heeke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2014
Circulating CD4+ T cells that produce IL4 or IL17 when stimulated by melan-A but not by NY-ESO-1 have negative impacts on survival of patients with stage IV melanoma
Henning Zelba, Benjamin Weide, Alexander Martens, et al.
Immunity & Ageing : I & A
|
September 9, 2010
Immunosenescence and Cytomegalovirus: where do we stand after a decade?
Graham Pawelec, Arne Akbar, Peter Beverley, et al.
Immunity & Ageing : I & A
|
June 8, 2023
Aging and chronic inflammation: highlights from a multidisciplinary workshop
Danay Saavedra, Ana Laura Añé-Kourí, Nir Barzilai, et al.
Journal of Translational Medicine
|
November 7, 2012
A novel series of conferences tackling the hurdles confronting the translation of novel cancer immunotherapies
Adrian Bot, Mark Ahn, Marnix Bosch, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 8, 2017
Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients
Kilian Wistuba-Hamprecht, Alexander Martens, Florian Heubach, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 12, 2016
Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab
Kilian Wistuba-Hamprecht, Alexander Martens, Karin Haehnel, et al.
Journal for Immunotherapy of Cancer
|
December 22, 2021
Early disappearance of tumor antigen-reactive T cells from peripheral blood correlates with superior clinical outcomes in melanoma under anti-PD-1 therapy
Jonas Bochem, Henning Zelba, Janine Spreuer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 21, 2016
Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab
Alexander Martens, Kilian Wistuba-Hamprecht, Marnix Geukes Foppen, et al.
Nature Medicine
|
July 3, 2026
Immune aging biomarkers for clinical trials
Andrea Cipriano, Jamie Justice, Jesse R Poganik, et al.
Page
of 35
Search research articles
Search
Showing results (321-330 of 349) with videos related to
Sort By:
Page
of 35
Frontiers in Immunology
|
July 25, 2022
Dynamics of Melanoma-Associated Epitope-Specific CD8+ T Cells in the Blood Correlate With Clinical Outcome Under PD-1 Blockade
Andrea Gaißler, Trine Sundebo Meldgaard, Christina Heeke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2014
Circulating CD4+ T cells that produce IL4 or IL17 when stimulated by melan-A but not by NY-ESO-1 have negative impacts on survival of patients with stage IV melanoma
Henning Zelba, Benjamin Weide, Alexander Martens, et al.
Immunity & Ageing : I & A
|
September 9, 2010
Immunosenescence and Cytomegalovirus: where do we stand after a decade?
Graham Pawelec, Arne Akbar, Peter Beverley, et al.
Immunity & Ageing : I & A
|
June 8, 2023
Aging and chronic inflammation: highlights from a multidisciplinary workshop
Danay Saavedra, Ana Laura Añé-Kourí, Nir Barzilai, et al.
Journal of Translational Medicine
|
November 7, 2012
A novel series of conferences tackling the hurdles confronting the translation of novel cancer immunotherapies
Adrian Bot, Mark Ahn, Marnix Bosch, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 8, 2017
Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients
Kilian Wistuba-Hamprecht, Alexander Martens, Florian Heubach, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 12, 2016
Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab
Kilian Wistuba-Hamprecht, Alexander Martens, Karin Haehnel, et al.
Journal for Immunotherapy of Cancer
|
December 22, 2021
Early disappearance of tumor antigen-reactive T cells from peripheral blood correlates with superior clinical outcomes in melanoma under anti-PD-1 therapy
Jonas Bochem, Henning Zelba, Janine Spreuer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 21, 2016
Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab
Alexander Martens, Kilian Wistuba-Hamprecht, Marnix Geukes Foppen, et al.
Nature Medicine
|
July 3, 2026
Immune aging biomarkers for clinical trials
Andrea Cipriano, Jamie Justice, Jesse R Poganik, et al.
Page
of 35